DeFronzo as Chief Medical Officer. He is a Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio, as well as Deputy ...
News
- OG Acquisition 2 Corp Provides Update on Business Combination with Concenter ...
- UT Health San Antonio launches clinical trial to study rapamycin and healthy aging
SAN ANTONIO, March 25, 2026 – UT Health San Antonio, the academic ... biomedical sciences and public health that are leading change and ...
- Meet the 2026 Alamo Heights ISD school board candidates - San Antonio Report
... San Antonio Report. Nonprofit journalism for an ... Bianca Cerqueira is a neuroscientist who works on federally sponsored biomedical research.
- OG Acquisition 2 Corp Provides Update on Business Combination with Concenter ...
Ralph A. DeFronzo as Chief Medical Officer. He is a Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio, as well as ...
- bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath ...
SAN ANTONIO--(BUSINESS WIRE)--$BIAF #BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive ...